From ‘wearables to ther-ables’

BY David Salazar

Unit shipments for wearable devices were expected to drive about $32 billion in revenue by 2019 — more than three times the $10 billion in revenue the market saw in 2013, according to a 2015 IHS Technology white paper on the wearables market. Beside the business applications IHS identified, it also focused on consumer possibilities in the wearables market — as fitness trackers, health data collectors and beyond.  

The potential that IHS identified is something that entrepreneurs are currently working on tapping into, and industry observers have taken note of the evolving role of wearables. Most notably, at the end of 2015, Fortune predicted that 2016 would be the year conventional thinking around wearable technology would change. The magazine predicted that this year “‘wearables’ will become ‘ther-ables.’” That is, wearables would evolve from simply tracking wellness data to actively working to keep users well.

The next generation of wearables, unlike those designed to track steps and monitor sleep — whether sold by Jawbone, Fitbit or Apple — is working to provide therapeutic value to users. Drug Store News found three companies that are at the forefront of revising what wearables can do, and how they can help users with chronic pain, those looking to quit smoking and those whose maintenance medications could use an upgrade.

Much of the buzz coming out of the annual South by Southwest festival has to do with the festival’s music and film components, but for 17 years, SXSW Interactive has celebrated innovation in various fields, including wearable technology. This year, the Waltham, Mass.-based NeuroMetrix won the top award in that category for its Quell Wearable Pain Relief Technology.

The $249 device — which sells on Quell’s website, Amazon, and hit and about 500 stores in mid-April — is worn around the calf and uses electrodes to stimulate sensory nerves, which send neural pulses to the brain, triggering a pain-relief response. Unlike TENS devices, Quell uses a different type of nerve stimulation to deliver what the company says is more powerful pain relief that customizes itself to the user through Quell’s OptiTherapy. Quell is approved by the Food and Drug Administration with indications for temporary pain relief, and management and relief of chronic pain. In clinical trials, the company has seen 81% of participants report an improvement in pain.

NeuroMetrix SVP and general manager of consumer health Frank McGillin said Quell is aimed at providing a service to a population that hasn’t been served by the current crop of wearable products.

“Today, in terms of a serious therapeutic wearable device for chronic pain, we’re pretty unique,” McGillin said. “There’s been an adoption of fitness trackers … and obviously rapid growth of those primarily around the worried well — they’re either active people trying to be even more active or they’re focused on their health. But there’s this large population of Americans suffering from chronic disease, and current devices aren’t addressing what their needs are.”

In some cases of chronic pain — which the most recent survey by the National Institute of Health says affects nearly 50 million Americans — addressing patient needs also can reduce medication use. In clinical trials, about two-thirds of participants reduced their medication use when using Quell, which McGillin said makes Quell a versatile treatment, potentially replacing medication in some cases, though he stressed that patients should consult their doctors on those matters.

“Looking at some of the big problems to be solved, chronic pain ranks up there. I think $50 billion [is] spent on the treatment of chronic pain, yet [more than] half the people are saying their pain isn’t adequately controlled. So we’re new as a technology, new as a brand, and we’re trying to both build the awareness and make Quell available to the people it’ll help,” he said.

Chrono Therapeutics
For years, the nicotine patch has been the most recognizable option to help people quit smoking, but Chrono Therapeutics’ smoking cessation solution is looking to give the nicotine patch a run for its money.

Chrono currently is developing a smoking cessation device featuring a wearable pod that acts as a nicotine delivery system. The pod will deliver nicotine to users based on when smokers have their strongest cravings. Users can even enter their typical wake-up time into pod to ensure that it begins dispensing nicotine about 90 minutes before the user wakes up, curbing their urge for a cigarette in the morning.

Chrono plans to file for FDA approval and has been working on clinical trials. Recently, the company conducted a small test to see how the device impacts nicotine cravings. Looking at 24 smokers, the test found a statistically significant reduction in cravings among the group receiving nicotine when compared with the placebo group.

“That was very encouraging to us because we had been told going into this trial that with such a small sample size of just 24 people — and also for just a 30-hour test — we might not see differences between the drug and the placebo, and the cravings might be essentially the same,” Chrono Therapeutics VP product management and marketing Jenny Hapgood said. “And yet, we did see statistically significant and clinically meaningful differences, which is giving us strong indicators that our product is more effective at helping people reduce their nicotine cravings.”

Going hand in hand with the nicotine delivery is the device’s accompanying coaching app, which looks to tackle the second challenge facing smokers — behavioral changes. The app, which Chrono hopes to have ready for user beta-testing in June, will use data collected by the pod to customize coaching and proactively remind users to power through cravings and stay on track. The app development is being partially funded by Chrono’s second Fast Tack Small Business Innovation Research grant from the National Cancer Institute.

For the Chrono team, the smoking cessation solution — whose consumer launch is anticipated in 2018 assuming regulatory approval and development are on track — also is providing a service that it believes wearables should.

“We think it’s all about this convergence where you have to have personalized therapy; you need to leverage the user’s data to impact the way that therapy works, and you need to have the digital health component because behavior change is always part of the story — whether it’s changing an addictive behavior or just being compliant with the clinical regimen you’ve been assigned,” Hapgood said. “We don’t think wearables anymore should just be tracking your data; something needs to happen. From that data, it needs to impact the therapy rather than just stop at awareness building.”

One of West Pharmaceutical Services’ areas of expertise is in self-injection technology, which includes the SelfDose self-injector system and the ConfiDose auto-injector system. But as medication gets more sophisticated, particularly in the case of biologic drugs, West is looking to make drug delivery more sophisticated, as well. The SmartDose electronic wearable injector is a delivery system designed to improve the patient experience and encourage medication adherence. The company is anticipating a commercial launch for SmartDose with one strategic customer later in 2016.
Patients can place the SmartDose injector on their abdomen, allowing them to be mobile during the required dosing time. It is different from some other wearables in that it does not collect data, and the first version of the SmartDose injector does not have smartphone connectivity. However, even without the bells and whistles that it expects to add in its second iteration, the device is looking to fill a therapeutic need.

“With the viscosities [of biologics] and protein concentrations going up, and thus the injected volumes going up, there really was this unmet need in the market that both us and other companies have capitalized on in the last three-plus years,” West’s VP of global innovation Chris Evans said.

Evans said the question, as the volume of biologics has gone up, is how to effectively get large doses in to patients, in something of a bolus, across multiple disease states. This led to an open-ended approach to developing the SmartDose platform used by different patient types and adaptable for use with varied molecules and treatments.

“It really opens up the doors for emerging therapies, beyond how you would traditionally think of drugs being delivered,” Evans said.

West has partnered with HealthPrize Technologies on a rewards program for patients. This means patients can earn points by scanning the barcode on their medication or otherwise “checking in” with the smartphone application and engaging with its disease-specific educational material, health tips and other content. Both of these efforts are aimed at improving adherence and keeping patients engaged with their regimen.

“It’s really not only about the delivery system and the patients’ interactions with it — it’s their interactions from the day they walk into the doctor’s office … and are prescribed something that happens to be delivered to them in a delivery system, which they now may need to inject themselves with. So, how can we help enhance that whole experience?” Evans asked. “But also from an ongoing perspective, how can you keep connected with them on a daily or weekly basis and instill confidence with self-administration?”

Beside the rewards program, West has looked to keep patients engaged by ensuring that they begin treatment and know how to properly use the delivery system. The company looks to patient onboarding and training company Noble to help patients using the SmartDose platform learn best practices for use with their medication.

“New patients with self-injectors often make errors in administration. Therefore, it is not surprising that when patients don’t have the necessary education and resources to use their self-injection system as intended, desired patient outcomes are not achieved,” Noble EVP Craig Baker said. “Research from both West and Noble revealed that patient-friendly delivery systems and comprehensive education around self-injection are needed to improve the patient experience along their journey.”

The hope is that, between personalized training and the potential for rewards, patients will be more adherent — improving outcomes and reducing the cost that nonadherence has on the entire healthcare system.

“One of the things Noble and HealthPrize helped us realize is that you also may need incentive and motivation to get people to spend the appropriate time with a trainer to maximize their learning,” Evans said. “It can all connect together if you give people the proposed value that makes it worthwhile and engaging.”


Leave a Reply

No comments found



Five ways to break through without breaking the bank

BY Michael Johnsen

Ahold’s Giant Carlisle newspaper insert ad

1. Avoid trying to swim with the big fish before you’re ready
In many health and beauty care categories, a majority of trade promotions are allocated to the few. Massive trade budgets enable large companies to capture a large portion of premium space. According to Market Track’s promotional data, the top 10 HBC manufacturers have maintained just under 70% share of all HBC promotions in print, online and email combined from 2013 to 2015. That leaves about 30% share to be divided between the hundreds of other manufacturers in the space.

As manufacturers grow their businesses, opportunities to expand trade promotion programs will arise. Being strategic in spotting areas where companies can capture ad share requires a systematic process to monitor promotions, as well as the ability to adjust course when necessary. Waiting until a company is in a position to make an impact will increase the likelihood of greater return on investment.

2. Keep lines of communication open
Many manufacturers believe that unless they invest a ton into trade promotion, it is difficult to get a seat at the table with their retailer partners, according to Market Track. It is common, for smaller companies especially, to be resigned to the idea that retailers will ultimately promote the brands and products they want to promote, and that it all goes back to dollars.

Market Track suggests remaining diligent. Communicate openly and regularly with the buyer’s desk to learn more about their process. Arming yourself with data to support your case shows that you have done your homework. Ask about creative ways in which additional support for brands and products can be a mutual win. And most importantly, share what has worked elsewhere. Success stories are a great resource to lean on for manufacturers with limited budgets, as nobody knows your business, or how to sell your product better than you do.

3. Explore digital opportunities
The cost of gaining meaningful presence in the print circular can sometimes be prohibitive. There is endless competition for space, and retailers must cover their costs for production and distribution.

The good news, according to Market Track, is that there are plenty of other opportunities to gain promotional support from retailer partners, and many reside in the digital space. The cost of sending an email promotion, posting to social media or running a promotion on a retailer’s website is comparatively small relative to the print circular. Also, digital is increasing in its impact. A 2016 survey conducted by Market Track found that consumers across all demographics use a variety of advertising media to inform their purchase decisions. Nearly 70% of shoppers between the ages of 21 to 49 years seek deals on retailer and brand websites. More than half of those between the ages of 21 to 39 years turn to social media in search of promotions. Not only is digital a cost-conscious alternative to the print circular, but certain digital media also is used by different shopper segments as much, if not more, than print.

This opens the door for younger, smaller suppliers to focus their discussion on digital media when meeting with their retailer partners. Market Track suggests making it a goal to broach the digital subject in every conversation with retailers, and if possible, reference past successes when your brands see a lift in sales resulting from a digital promotion.

4. Execute flawlessly when you are featured
Companies that spend billions on advertising and trade promotions each year expect to have a presence in most print circulars that their retailers publish throughout the year. Manufacturers with only a fraction of their trade budget, however, may be able to count their annual promotional impressions on one hand. For these companies, executing a quality promotion is critically important, according to Market Track.

What makes a promotion high quality? There are a variety of factors that all contribute to a successful promotion, Market Track stated. First, retailers should portray their brands and products in the same manner they advertise them. If you make a brand promise in your own TV commercial or digital advertisement, you do not want retailers sending a different message. This will help avoid creating confusion in the mind of the shopper about a brand, what it means to them, if they prefer it over alternatives, and whether or not they ultimately want to buy one brand over another.

Second, be competitive on price without sacrificing brand equity, said Market Track. Give shoppers a compelling incentive to buy the product today, but do not set an inaccurate perception of what they should pay for the products.

And finally, think strategically about scheduled promotional placements. Are there opportunities to improve page location, the size of the ad or placement relative to other categories within the circular? These questions should always be a part of
the dialogue with the buyer’s desk. At the very least, it lets them know that you are thinking about how to improve the performance of your promotions.

5. Take the time and invest the resources to understand what works
Many of these tactics Market Track shared are ideal for companies trying to avoid breaking the bank on gaining promotional exposure. Call it ironic, then, that the final idea Market Track suggests is advocating for investing time and resources. Do not spend those resources just anywhere, according to Market Track. Rather, it is important to measure the success of all advertising in which you participate.

Emerging brands must have an elaborate understanding of the advertising and promotional tactics that result in the greatest “bang for the buck.” This requires time and resources spent on monitoring lifts and dips in sales performance, shopper insights and competitive activity in concert with advertising. Manufacturers have to know who their target shoppers are, how competition tries to engage them and through which media channels products see the optimal sales lift when advertised.

Consistent measurement of your business will give you a competitive advantage over other companies that are in similar situations, said Market Track. Manufacturers will be able to share with retailer partners the blueprint for selling more of their product — which is ultimately the name of the game in the retail industry.


Leave a Reply

No comments found



J&J Consumer names Twigg chief customer officer

BY David Salazar
NEW BRUNSWICK, N.J. — Johnson & Johnson Consumer recently announced that it had appointed industry veteran Chester Twigg to the position of chief customer officer for its family of consumer companies. Twigg will report to the company’s worldwide chairman of J&J Consumer, Jorge Mesquita. 
Twigg’s role will see him playing a key role executing the company’s global consumer strategy, as well as developing new ways of selling to maximize growth and value creation. 
Twigg joins J&J from Procter & Gamble, where he was most recently VP sales for its global baby, feminine care and family care categories. He spent 20 years at P&G, where he drove business growth and built customer relationships in China, India, Eastern and Western Europe and the United States. He will relocate from Singapore to New Brunswick. 


Leave a Reply

No comments found